Literature DB >> 8426745

Neoplastic transformation of a human keratinocyte cell line by the v-fos oncogene.

M S Lee1, J H Yang, Z Salehi, P Arnstein, L S Chen, G Jay, J S Rhim.   

Abstract

To analyze the role of the fos oncogene in the growth of human epithelial cells, we have transfected a non-tumorigenic human epidermal keratinocyte line (RHEK-1) immortalized by the Ad12-SV40 hybrid virus with a plasmid carrying the v-fos gene together with plasmid pSV2-neo which confers resistance to neomycin. Individual neomycin-resistant clones were isolated and characterized with respect to morphological alteration. Of 16 independent clones analyzed, two appeared morphologically transformed and formed foci in culture. Only the two clones with a transformed phenotype were found by Southern blot hybridization analysis to contain the transfected v-fos gene. These clones formed colonies in soft agar and induced tumors when transplanted into nude mice. Analysis of fos specific mRNA and protein demonstrated that the transfected v-fos gene was expressed in these two clonal lines. These findings suggest that expression of the v-fos gene might facilitate the process of neoplastic transformation of human epithelial cells in culture. This appears to represent the first demonstration of the transforming potential of the v-fos gene in human cells.

Entities:  

Mesh:

Year:  1993        PMID: 8426745

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  2 in total

1.  Induction of apoptosis by c-Fos protein.

Authors:  G A Preston; T T Lyon; Y Yin; J E Lang; G Solomon; L Annab; D G Srinivasan; D A Alcorta; J C Barrett
Journal:  Mol Cell Biol       Date:  1996-01       Impact factor: 4.272

2.  Differential expression of matrix metalloproteinases in activated c-ras-Ha-transfected immortalized human keratinocytes.

Authors:  L C Meade-Tollin; P Boukamp; N E Fusenig; C P Bowen; T C Tsang; G T Bowden
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.